Rating: Analysts assign qualitative assessments to stocks, ranging from 'Outperform' to 'Underperform'. These ratings convey the analysts' expectations for the relative performance of Teva ...

which it says focuses on pharmacy benefit managers’ influence over specialty generic drugs, “including significant price markups by PBMs for cancer, HIV, and a variety of other critical drugs.” ...

(CNN) — Pharmacy benefit managers, which serve as the middlemen between drug makers, insurers and pharmacies, reaped $7.3 billion in revenue from marking up the prices of dozens of specialty ...

Teva cannot market its generic version of Firdapse in the U.S. before February 25, 2035, unless specific conditions arise. Ongoing Firdapse patent litigation continues against Hetero and Lupin ...

Status: Needs Triage Issue will be reviewed by Core Team and a relevant label will be added as soon as possible ...

December 23, 2024, the U.S. Food and Drug Administration approved the first generic referencing Victoza (liraglutide injection) 18 milligram/3 milliliter, a glucagon-like peptide-1 (GLP-1) receptor ...

For patients who have been paying for Ozempic or other glucagon-like peptide-1 medications, there may be another beneficial development: On December 23, the U.S. Food and Drug Administration (FDA) ...

The Mail and Calendar apps are now past their end-of-support deadline (December 31, 2024), and they could stop working at any moment. It’s been over six months since Microsoft announced that it ...

The Generic PnP monitor driver in Windows allows external monitors to be used without manually installing specific drivers. It defaults to this when it can't find a suitable driver for the monitor ...